P1.14-61 EGFR Inhibitors Plus Bevacizumab Are Superior Compared to EGFR Inhibitor Monotherapy in Advanced EGFR+ NSCLC Patients with BIM Deletions
| Autor: | Cardona, A.F., Arrieta, O.G., Ruiz-Patiño, A., Barrón, Z.L. Zatarain, Rojas, L.L., Corrales, L., Martin, C., Barrón, F., Sotelo, C., Rodriguez, J., Ricaurte, L., Ávila, J., Mayorga, D., Archila, P., Otero, J., Freitas, H., De Lima, V. Cordeiro, Mas, L., Carranza, H., Vargas, C., Rosell, R. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology October 2019 14(10) Supplement:S579-S579 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|